hrcak mascot   Srce   HID

Pregledni rad

CARBAPENEMASES OF GRAM-NEGATIVE BACTERIA

Branka Bedenić
Sanda Sardelić
Mirna Vranić-Ladavac
Nada Barišić
Ranko Ladavac

Puni tekst: hrvatski, pdf (424 KB) str. 0-0 preuzimanja: 169* citiraj
APA 6th Edition
Bedenić, B., Sardelić, S., Vranić-Ladavac, M., Barišić, N. i Ladavac, R. (2014). KARBAPENEMAZE GRAM-NEGATIVNIH BAKTERIJA. Liječnički vjesnik, 136 (3-4), 0-0. Preuzeto s https://hrcak.srce.hr/172597
MLA 8th Edition
Bedenić, Branka, et al. "KARBAPENEMAZE GRAM-NEGATIVNIH BAKTERIJA." Liječnički vjesnik, vol. 136, br. 3-4, 2014, str. 0-0. https://hrcak.srce.hr/172597. Citirano 20.10.2019.
Chicago 17th Edition
Bedenić, Branka, Sanda Sardelić, Mirna Vranić-Ladavac, Nada Barišić i Ranko Ladavac. "KARBAPENEMAZE GRAM-NEGATIVNIH BAKTERIJA." Liječnički vjesnik 136, br. 3-4 (2014): 0-0. https://hrcak.srce.hr/172597
Harvard
Bedenić, B., et al. (2014). 'KARBAPENEMAZE GRAM-NEGATIVNIH BAKTERIJA', Liječnički vjesnik, 136(3-4), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172597 (Datum pristupa: 20.10.2019.)
Vancouver
Bedenić B, Sardelić S, Vranić-Ladavac M, Barišić N, Ladavac R. KARBAPENEMAZE GRAM-NEGATIVNIH BAKTERIJA. Liječnički vjesnik [Internet]. 2014 [pristupljeno 20.10.2019.];136(3-4):0-0. Dostupno na: https://hrcak.srce.hr/172597
IEEE
B. Bedenić, S. Sardelić, M. Vranić-Ladavac, N. Barišić i R. Ladavac, "KARBAPENEMAZE GRAM-NEGATIVNIH BAKTERIJA", Liječnički vjesnik, vol.136, br. 3-4, str. 0-0, 2014. [Online]. Dostupno na: https://hrcak.srce.hr/172597. [Citirano: 20.10.2019.]

Sažetak
Carbapenems are often antibiotics of last resort for the treatment of severe infections. They are stable to most b-lactamases produced by gram-negative bacteria. However, bacterial enzymes named carbapenemases can efficiently hydrolyze carbapenems. They are produced most frequently by Enterobacteriaceae and non-fermentative bacteria such as Pseudomonas aeruginosa and Acinetobacterbaumannnii. They belong to group A (KPC, SME, IMI, NMC), B (VIM, IMP, SPM, GIM, NDM, SIM, DIM, AIM) and D (OXA-23, OXA-24, OXA-48, OXA-58, OXA-143). The accurate and rapid laboratory identification of carbapenem-resistant isolates is important to prevent spread of such multidrug resistant strains and to avoid therapeutic failures. Therapeutic options are often limited because carbapenemases are encoded on mobile genetic elements which often harbour resistance genes to other groups of antibiotics. Thus, colistin is often the only therapeutic option.

Ključne riječi
Gram-negative bacteria – enzymology, genetics, drug effects; Beta-lactamases – classification, genetics, metabolism; Bacterial proteins – classification, genetics, metabolism; Gram-negative bacterial infections – microbiology, drug therapy, prevention and control; Carbapenems – pharmacology; Anti-bacterial agents – pharmacology; Beta-lactam resistance

Hrčak ID: 172597

URI
https://hrcak.srce.hr/172597

[hrvatski]

Posjeta: 421 *